메뉴 건너뛰기




Volumn 81, Issue 7, 2015, Pages 705-708

Selective digestive decontamination: A pre-emptive treatment for a few european ecological niches or a worldwide implementation?

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; TOBRAMYCIN; ANTIINFECTIVE AGENT;

EID: 84937835727     PISSN: 03759393     EISSN: 18271596     Source Type: Journal    
DOI: None     Document Type: Editorial
Times cited : (1)

References (24)
  • 1
    • 0016772223 scopus 로고
    • Protected environment and intestinal decontamination in acute leukemia
    • Klastersky J, Hensgens C, Debusscher L. Protected environment and intestinal decontamination in acute leukemia. Acta Clin Belg 1975;30:327-32.
    • (1975) Acta Clin Belg , vol.30 , pp. 327-332
    • Klastersky, J.1    Hensgens, C.2    Debusscher, L.3
  • 2
    • 0016293860 scopus 로고
    • Oral dose and faecal concentration of antibiotics during an-tibiotic decontamination in mice and in a patient
    • van der Waaij D, Berghuis-de Vries JM, Korthals Altes C. Oral dose and faecal concentration of antibiotics during an-tibiotic decontamination in mice and in a patient. J Hyg (Lond) 1974;73:197-203.
    • (1974) J Hyg (Lond) , vol.73 , pp. 197-203
    • Van Der Waaij, D.1    Berghuis-de Vries, J.M.2    Korthals Altes, C.3
  • 3
    • 0021063528 scopus 로고
    • A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract
    • Stoutenbeek CP, Van Saene HK, Miranda DR, Zandstra DF. A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract. Acta Anaesthesiol Belg 1983;34:209-21.
    • (1983) Acta Anaesthesiol Belg , vol.34 , pp. 209-221
    • Stoutenbeek, C.P.1    Van Saene, H.K.2    Miranda, D.R.3    Zandstra, D.F.4
  • 4
    • 84898002266 scopus 로고    scopus 로고
    • SuDDICU Collaboration: Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: Systematic review and network meta-analysis
    • Price R, MacLennan G, Glen J, SuDDICU Collaboration: Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 2014;348:g2197.
    • (2014) BMJ , vol.348 , pp. g2197
    • Price, R.1    MacLennan, G.2    Glen, J.3
  • 5
    • 79958783213 scopus 로고    scopus 로고
    • Selective digestive decontamination. Why are intensivists more "resistant" than microorganisms?
    • Silvestri L, Petros AJ, De La Cal MA, Visintin S. Selective digestive decontamination. Why are intensivists more "resistant" than microorganisms? Minerva Anestesiol 2011;77: 658-9.
    • (2011) Minerva Anestesiol , vol.77 , pp. 658-659
    • Silvestri, L.1    Petros, A.J.2    De La Cal, M.A.3    Visintin, S.4
  • 6
    • 84937853994 scopus 로고    scopus 로고
    • Use of selective digestive tract decontamination in European intensive cares: The ifs and whys
    • Reis Miranda D, Citerio G, Perner A, Dimopoulos G, Torres A, Hoes A et al. Use of selective digestive tract decontamination in European intensive cares: the ifs and whys. Minerva Anestesiol 2015;81:734-42.
    • (2015) Minerva Anestesiol , vol.81 , pp. 734-742
    • Reis Miranda, D.1    Citerio, G.2    Perner, A.3    Dimopoulos, G.4    Torres, A.5    Hoes, A.6
  • 7
    • 13844254907 scopus 로고    scopus 로고
    • ESAC Project Group: Outpatient antibiotic use in Europe and association with resistance: A cross-national database study
    • Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
    • (2005) Lancet , vol.365 , pp. 579-587
    • Goossens, H.1    Ferech, M.2    Vander Stichele, R.3    Elseviers, M.4
  • 8
    • 0141537234 scopus 로고    scopus 로고
    • Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: A randomised controlled trial
    • de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003;362:1011-6.
    • (2003) Lancet , vol.362 , pp. 1011-1016
    • De Jonge, E.1    Schultz, M.J.2    Spanjaard, L.3    Bossuyt, P.M.4    Vroom, M.B.5    Dankert, J.6
  • 10
    • 84897463412 scopus 로고    scopus 로고
    • Redefining the gut as the motor of critical illness
    • Mittal R, Coopersmith CM. Redefining the gut as the motor of critical illness. Trends Mol Med 2014;20:214-23.
    • (2014) Trends Mol Med , vol.20 , pp. 214-223
    • Mittal, R.1    Coopersmith, C.M.2
  • 11
    • 84897438156 scopus 로고    scopus 로고
    • Obesity and cancer: A gut microbial connection
    • Ohtani N, Yoshimoto S, Hara E. Obesity and cancer: a gut microbial connection. Cancer Res 2014;74:1885-9.
    • (2014) Cancer Res , vol.74 , pp. 1885-1889
    • Ohtani, N.1    Yoshimoto, S.2    Hara, E.3
  • 12
    • 84905586295 scopus 로고    scopus 로고
    • Microbiota and diabetes: An evolving relationship
    • Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut 2014;63:1513-21.
    • (2014) Gut , vol.63 , pp. 1513-1521
    • Tilg, H.1    Moschen, A.R.2
  • 14
    • 84908608590 scopus 로고    scopus 로고
    • The gut microbiota, bacterial metabolites and colorectal cancer
    • Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 2014;12:661-72.
    • (2014) Nat Rev Microbiol , vol.12 , pp. 661-672
    • Louis, P.1    Hold, G.L.2    Flint, H.J.3
  • 15
    • 84927668122 scopus 로고    scopus 로고
    • Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus
    • Allin KH, Nielsen T, Pedersen O. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus. Eur J Endocrinol 2015;172:R167-77.
    • (2015) Eur J Endocrinol , vol.172 , pp. R167-R177
    • Allin, K.H.1    Nielsen, T.2    Pedersen, O.3
  • 21
    • 0033635312 scopus 로고    scopus 로고
    • Opinion: The clinical use of selective digestive decontamination
    • Kollef MH. Opinion: the clinical use of selective digestive decontamination. Crit Care 2000;4:327-32.
    • (2000) Crit Care , vol.4 , pp. 327-332
    • Kollef, M.H.1
  • 23
    • 84907698058 scopus 로고    scopus 로고
    • Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: A randomized clinical trial
    • Oostdijk EA, Kesecioglu J, Schultz MJ, Visser CE, de Jonge E, van Essen EH et al. Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial. JAMA 2014;312:1429-37.
    • (2014) JAMA , vol.312 , pp. 1429-1437
    • Oostdijk, E.A.1    Kesecioglu, J.2    Schultz, M.J.3    Visser, C.E.4    De Jonge, E.5    Van Essen, E.H.6
  • 24
    • 84880147971 scopus 로고    scopus 로고
    • Dutch SOD-SDD trialists group: Effects of decontamination of the digestive tract and oropharynx in intensive care unit patients on 1-year survival
    • Oostdijk EA, de Smet AM, Bonten MJ, Dutch SOD-SDD trialists group: Effects of decontamination of the digestive tract and oropharynx in intensive care unit patients on 1-year survival. Am J Respir Crit Care Med 2013;188:117-20.
    • (2013) Am J Respir Crit Care Med , vol.188 , pp. 117-120
    • Oostdijk, E.A.1    De Smet, A.M.2    Bonten, M.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.